Remarkably, Siglec-9 expression on CD8+ T cells present in peripheral blood and tumor tissue of non-small cell lung cancer (NSCLC) patients is upregulated up to 25% and 40% respectively (11). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.